Peninsula Energy

Penumbra, Inc. designs, develops, manufactures, and markets innovative medical devices globally. The company specializes in aspiration-based thrombectomy systems and neurovascular solutions, addressing critical healthcare needs.

Products and Services

• Thrombectomy systems for vascular applications under the Indigo System brand
• Neurovascular embolization coiling systems for aneurysms and lesions
• Neurosurgical aspiration tools for tissue and fluid removal

Growth Outlook

• Revenue growth of 8.6% year-over-year in Q4 2025
• Strong demand for neurovascular products driving market expansion
• Investment in R&D to enhance product offerings and innovation

Financial Highlights

• Q4 2025 net income of $47.34 million, reflecting a 12.28% net profit margin
• TTM revenue of $1.46 billion, with a gross profit margin of 67.14%
• Current ratio of 6.64, indicating strong liquidity position

Penumbra, Inc. has established itself as a leader in the medical device industry, particularly in neurovascular and vascular solutions. The company's commitment to innovation is evident in its robust product portfolio, which addresses critical medical needs. Recent financial performance highlights a solid revenue trajectory, with a notable increase in net income and strong profit margins. The company's liquidity position is also commendable, providing a cushion for future growth initiatives. With ongoing investments in research and development, Penumbra is well-positioned to capitalize on emerging opportunities in the healthcare sector.